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8 The Journal of Thoracic and Cardiovbjective: We sought to develop risk-adjusted morbidity and mortality models to
ompare the performance of 2 different thoracic surgery units in patients submitted
o major lung resections.
ethods: Seven hundred forty-three patients (551 male and 192 female patients)
ho underwent lobectomy (n  611) or pneumonectomy (n  132) from January
000 through August 2004 at 2 European thoracic units (519 patients in unit A and
24 patients in unit B) were analyzed. Risk-adjusted models of 30-day or in-hospital
ardiopulmonary morbidity and mortality were developed by using stepwise logistic
egression analyses and validated by means of bootstrap analysis. Preoperative and
perative variables were initially screened by using univariate analysis. Those with
P value of less than .10 were used as independent variables in the regression
nalyses. The regression equations were then used to estimate the risk of outcome,
nd the observed and predicted outcome rates of the 2 units were compared by using
he z test for comparison of proportions.
esults: The following regression models were developed. Predicted morbidity:
n R⁄1  R   2.4  0.03Xage  0.02XppoFEV1  0.6Xcardiac comorbidity
Hosmer-Lemeshow statistic  6.1 [P  .6], c index  0.65). Predicted mortality:
n R⁄1  R   6.97  0.095Xage  0.042XppoFEV1 (Hosmer-Lemeshow
tatistic  2.99 [P  .9], c index  0.77). The models proved to be stable at
ootstrap analyses. No differences were noted between observed and predicted
utcome rates within each unit, despite an apparent unadjusted better performance
f unit B.
onclusions: The use of risk-adjusted outcome models avoided misleading infor-
ation derived from the unadjusted analysis of performance. Risk modeling is
ssential for the evaluation of the quality of care.
n the present era of managed care systems, increasing pressure is exerted by
payers and the public on the profession to assume greater responsibility for
delivering high-quality care. Accountability demands an increased effort in
uality-monitoring and quality-improvement processes through the analysis of
erformance of health care providers. However, because patients are not randomly
llocated to different physicians or hospitals and their outcome can be influenced by
llness severity, treatment effectiveness, or even mere chance,1,2 the comparison of
utcomes is challenging. Indeed, a different case mix at different institutions might
ake the comparison of crude outcome rates misleading. Therefore the selection of
uality end points must account for the differences in the prevalence of risk factors,
nd clinical risk modeling must become the logical and necessary approach for
rovider profiling. Nevertheless, risk modeling for audit purposes appears yet in its
mbryonic phase in thoracic surgery, and specific literature on this issue is scanty
nd mainly limited to internal audit.3-5
ascular Surgery ● January 2007
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G
TSThe objective of the present study was to develop risk-
djusted models of early morbidity and mortality after ma-
or lung resection and to compare the performance of 2
ifferent European thoracic surgery units with the intent to
rovide a methodological and practical example of model
uilding and application for multicentric comparative audit
urposes.
atients and Methods
e analyzed 743 patients treated with lobectomy/bilobectomy (n
611) or pneumonectomy (n  132) in 2 European centers (519
n center A and 224 in center B) from January 2000 through
ugust 2004.
This is an observational study performed on prospective, period-
cally audited electronic databases of two dedicated thoracic surgery
nits located in two different European countries. Data were entered
rospectively in each database by a trained staff physician and were
eriodically audited by a designated audit lead, who was responsible
or the accuracy and completeness of the database. Both databases are
sed as continuous quality-improvement instruments at the two par-
icipating units. The study was approved by the local institutional
eview board of each center, and informed consent to be entered in the
atabases was obtained from all patients.
The patients and datasets used for this study were the same
sed for a recently published analysis.6 Although the subject was
imilar (risk modeling), the focuses of the two analyses were
ifferent in that the first study aimed at demonstrating the superi-
rity of bootstrap analysis over the traditional training and test
ethod for developing risk models by constructing multiple mod-
ls from the population from unit A and then assessing their
alidity on the bootstrapped population of unit B.6 No comparison
etween the two units was performed because this was not the
bjective of that report. On the other hand, in this analysis the main
urpose was to compare the performance of the two units by
eveloping risk models from the entire dataset of patients (unit A
lus unit B) after validation by means of bootstrap analysis. For
his reason, we consider the two studies unique and independent.
In both centers surgical intervention was contraindicated in
hose patients with a predicted postoperative forced expiratory
olume in 1 second (ppoFEV1) and predicted postoperative carbon
onoxide lung diffusion capacity (ppoDLCO) of less than 30% of
redicted value in association with a poor exercise capacity (height
t maximal stair-climbing test 12 m or maximum oxygen con-
umption [VO2max] at cycle ergospirometry 10 mL · kg1
in1) or in the presence of hemodynamic instability, despite
Abbreviations and Acronyms
DLCO  carbon monoxide lung diffusion capacity
FEV1  forced expiratory volume in 1 second
ppoDLCO predicted postoperative carbon monoxide
lung diffusion capacity
ppoFEV1  predicted postoperative forced expiratory
volume in 1 second
VO2max maximum oxygen consumptionptimization of treatment. As a rule, lung resections were per- a
The Journal of Thoracormed through a muscle-sparing thoracotomy by certified thoracic
urgeons for benign (56 lobectomies and 2 pneumonectomies) or
alignant (555 lobectomies and 130 pneumonectomies; 667 pri-
ary and 18 metastatic diseases) diseases. The postoperative man-
gement policies were the same in both centers. All patients were
dmitted to a dedicated general thoracic surgery ward immediately
fter the operation, resorting to the intensive care unit only in case
f complications requiring invasive assisted ventilation or invasive
ontinuous monitoring. Postoperative treatment was standardized
n both units and focused on early mobilization, chest physiother-
py and physical rehabilitation, thoracotomy pain control, and
ntibiotic and antithrombotic prophylaxis. Postoperative chest pain
as controlled by means of epidural or continuous intravenous
nalgesia, which was titrated to keep the pain visual analogue
core at less than 4 (in a scale ranging from 0-10) for the first
ostoperative 48 to 72 hours (pain score was assessed twice daily
uring the morning and afternoon rounds).
Postoperative morbidity and mortality were considered as those
ccurring within 30 days postoperatively or for a longer period if
he patient was still in the hospital.
A number of preoperative and operative variables were tested
or possible association with outcome variables (see Appendix
4,5,7-9 for explanation of variables).
Data were initially scrutinized for assessing the quality of vari-
bles and their consistency in definition and recording between the 2
nits. To this purpose, the 2 databases were reciprocally and indepen-
ently audited by the principle investigator of the other unit (AB and
R). Only those variables and end points that were deemed of high
uality and consistent across the 2 units were included in this analysis.
he databases were made anonymous for both patients and surgeons
nd were merged for analysis. All patients were initially used to
evelop the predictive logistic models. For each measure of outcome
morbidity and mortality rates), variables were initially screened by
sing univariate analyses. The univariate comparisons of outcomes
ere performed by means of the unpaired Student t test for numeric
ariables with normal distribution and by means of the Mann–Whit-
ey U test for numeric variables without normal distribution. The
hapiro–Wilk normality test was used to assess normal distribution.
ategoric variables were compared by means of the 2 test or the
isher exact test, as appropriate.
Variables with a P value of less than .10 at univariate analysis
ere then used as independent variables in the stepwise logistic
egression analyses. The presence or absence of 1 or more com-
lications or of mortality was used as a dependent variable in each
espective model. All data were complete, with the exception of
ata on carbon monoxide lung diffusion capacity (DLCO), which
ere 95% complete. Missing data were imputed by averaging the
onmissing values. Potential explanatory variables more than 5%
ncomplete were excluded from this analysis (ergometric param-
ters [VO2max], blood gas analysis measures, and albumin con-
entration). To avoid multicollinearity, only 1 variable in a set of
ariables with a correlation coefficient of greater than 0.5 was
elected (by using the bootstrap procedure) and used in the regres-
ion model.
A P value of less than .05 was selected for retention of
ariables in the final model. The area under the receiver operating
haracteristic curve or c index was used to study the discrimination
bility of each model. Hosmer–Lemeshow goodness-of-fit statis-
ic and Cardiovascular Surgery ● Volume 133, Number 1 89
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G
TSics were used to assess the calibration of the models. Furthermore,
he multivariate procedures were validated by means of bootstrap
agging with 1000 samples. In the bootstrap procedure repeated
amples of the same number of observations as the original data-
ase (n  743) were selected with replacement from the original
et of observations. For each sample, stepwise logistic regression
as performed, entering the variables with a P value of less than
1 at univariate analysis. The stability of the final model can be
ssessed by identifying the variables that enter most frequently in
he repeated bootstrap models and comparing those variables with
he variables in the final model. If the final stepwise model vari-
bles occur in a majority (50%) of the bootstrap models, the
riginal final stepwise regression model can be judged to be
table.6,10,11 We have previously shown that bootstrap analysis
ight be particularly advantageous in moderate-sized samples
nasmuch as it allows the use of the entire dataset for model
eveloping without the need to split and further reduce the sample
ize (and the number of outcome cases).6
ABLE 1. Characteristics of the patients in the study (agg
ariables
All patients
(n  743)
ge (y) 65.2 (10.7)
lderly (70 years of age; n [%]) 275 (37)
MI (kg/m2) 25.9 (4.4)
EV1% 84.7 (18.9)
LCO% 78 (18.8)
poFEV1% 65.5 (17.3)
poDLCO% 60.4 (16.9)
ardiac comorbidity (n [%]) 287 (39)
eoadjuvant chemotherapy (n [%]) 85 (11)
neumonectomy (n [%]) 132 (18)
esults are expressed as means (standard deviations) unless otherwise ind
arbon monoxide lung diffusion capacity; ppoFEV1, predicted postoperative
onoxide lung diffusion capacity. *Mann–Whitney Test. †2 Test.
ABLE 2. Univariate comparison between patients with
atients
ariables
Complicated
(n  159)
Nonco
(n 
ge 68 (10.2) 64.4
ale sex (n [%]) 132 (83) 419
MI (kg/m2) 26.3 (4.1) 25.8
EV1% 80.3 (17.3) 85.9
LCO% 74.8 (19.6) 78.9
poFEV1% 62.1 (15.9) 66.5
poDLCO% 57.4 (15.6) 61.2
alignant disease (n [%]) 152 (96) 533
ardiac comorbidity (n [%]) 84 (53) 203
eoadjuvant chemotherapy (n [%]) 24 (15) 61
neumonectomy (n [%]) 32 (20) 100
esults are expressed as means (standard deviations) unless otherwise ind
arbon monoxide lung diffusion capacity; ppoFEV , predicted postoperative1
onoxide lung diffusion capacity. *Mann–Whitney test. †2 Test. ‡Fisher exac
0 The Journal of Thoracic and Cardiovascular Surgery ● JanuaThe logistic models were then used to predict morbidity and
ortality in the patients undergoing operations in the 2 different
nits. Predicted and observed outcome rates in each unit were then
ompared, and P values were calculated from the z test statistic for
he difference between two proportions, which uses the sampling
istribution of the statistic to guess population parameters. In the
est statistic the numerator is the difference between the proportion
n the two samples, and the denominator is the standard error of the
ifference in the two proportions.
All the statistical tests were two-tailed. The analysis was per-
ormed with STATA 8.2 (Stata Corp, College Station, Tex) sta-
istical software.
esults
he characteristics of the patients in the study are shown in
able 1.
Table 2 shows the results of the univariate comparison
te and by center)
Unit A
(n  519)
Unit B
(n  224)
Unit A vs unit B,
P value
66.9 (9.6) 61.3 (12.2) .0001*
220 (42) 55 (25) .0001†
26 (4.4) 25.6 (4.5) .3*
85 (19.3) 84 (18.2) .4*
76.5 (18.6) 81.4 (18.2) .005*
66.9 (16.9) 62.4 (17.8) .001*
60.3 (16.8) 60.6 (16.4) .5*
253 (49) 34 (15) .0001†
60 (12) 25 (11) 0.9†
90 (17) 42 (19) 0.6†
. BMI, Body mass index; FEV1, forced expiratory volume in 1 second; DLCO,
d expiratory volume in 1 second; ppoDLCO, predicted postoperative carbon
without complications and between dead and surviving
ated
) P value
Dead
(n  35)
Surviving
(n  708) P value
) .0001* 71.5 (6.7) 64.9 (10.8) .0001*
.004† 30 (86) 521 (74) .12‡
.2* 25.2 (4.4) 25.9 (4.4) .4*
) .0009* 74.9 (16.3) 85.2 (19) .002*
) .02* 71.3 (23) 78.3 (18.3) .05*
) .003* 56.1 (12.7) 66 (17.3) .0004*
) .03* 53.5 (18) 60.7 (16.6) .01*
0.07† 33 (94) 652 (92) 1‡
.0001† 20 (57) 267 (38) .02†
.1† 4 (11) 81 (11) 1‡
.4† 12 (34) 120 (17) .009†
. BMI, Body mass index; FEV1, forced expiratory volume in 1 second; DLCO,
d expiratory volume in 1 second; ppoDLCO, predicted postoperative carbonrega
icated
forceand
mplic
584
(10.7
(72)
(4.5)
(19.2
(18.3
(17.5
(16.9
(91)
(35)
(10)
(17)
icated
forcet test.
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G
TSetween patients with and without complications or mortal-
ty. In particular, compared with noncomplicated patients,
hose with complications were older (P .0001); had lower
orced expiratory volume in 1 second (FEV1; P  .0009),
LCO (P  .02), ppoFEV1 (P  .003), and ppoDLCO (P 
03) values; were more frequently male (P  .004); and had
higher prevalence of malignant disease (P  .07) and
ardiac comorbidities (P  .0001).
Compared with patients who survived, those who died
ere older (P  .0001); had lower FEV1 (P  .002), DLCO
P  .05), ppoFEV1 (P  .0004), and ppoDLCO (P  .01)
alues; and had a higher prevalence of cardiac comorbidi-
ies (P  .02) and pneumonectomies (P  .009).
Stepwise logistic regression analysis showed that signif-
cant and reliable predictors of morbidity were age (P 
005), ppoFEV1 (P  .003), and cardiac comorbidity (P 
002, Table 3).
The following equation predicting morbidity was devel-
ped:
n R ⁄ 1 R2.4 0.03Xage 0.02XppoFEV1
 0.6Xcardiac comorbidity
Hosmer–Lemeshow statistic  6.1 [P.6], c index 
.65). Stepwise logistic regression analysis showed that
ignificant and reliable predictors of mortality were age (P
.0002) and ppoFEV1 (P  .0004, Table 3).
The following equation predicting mortality was devel-
ped:
ln R ⁄ 1 R6.97 0.095Xage 0.042XppoFEV1
Hosmer-Lemeshow-statistic  2.99 [P.9], c index 
.77). Figure 1 plots the cumulative observed morbidity and
ortality rates against the predicted rates in patients ordered
y increasing risk of morbidity and mortality, respectively.
he plots showed overall good calibration of the models.
The stability of the models was evaluated by assessing
ABLE 3. Results of the stepwise logistic regression analys
arsimonious models
redictors Coefficients SE O
orbidity model
Intercept 2.4
Age 0.03 0.01
ppoFEV1% 0.02 0.006
Cardiac comorbidity 0.6 0.2
ortality model
Intercept 6.97
Age 0.095 0.03
ppoFEV1% 0.042 0.01
ootstrap frequency: frequency of significance (P  .05) in 1000 boot
ostoperative forced expiratory volume in 1 second.he distribution of the c index statistics across 1000 boot- c
The Journal of Thoractrap samples. The morbidity model c index was greater
han 0.6 in 99% of the samples and greater than 0.7 in 46%
f the samples. The mortality model c index was greater
han 0.6 in 100% of the samples and greater than 0.7 in 97%
f the samples.
ependent variables: morbidity and mortality, respectively):
atio 95% CL P value Bootstrap frequency
1.009-1.05 .005 80%
0.97-0.99 .003 88%
1.2-2.6 .002 89%
1.05-1.16 .0002 100%
0.94-0.98 .0004 98%
samples. SE, Standard error; CL, confidence limit; ppoFEV1, predicted
igure 1. A, Plot of cumulative predicted morbidity against ob-
erved morbidity ordered by increasing risk. B, Plot of cumulative
redicted mortality against observed mortality ordered by in-es (d
dds r
1.03
0.98
1.8
1.1
0.96
strapreasing risk.
ic and Cardiovascular Surgery ● Volume 133, Number 1 91
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G
TSWe observed differences in baseline and operative char-
cteristics between patients in unit A and those in unit B. In
articular, compared with patients in unit B, those operated
n in unit A were older (P .0001), had lower DLCO values
P  .005), and had a greater frequency of cardiac comor-
idities but had higher ppoFEV1 values (P  .001, Table 1).
Figure 2 depicts the distributions of the patients accord-
ng to increasing quartiles of expected risk of morbidity and
ortality in the 2 units, respectively. Unit A had a greater
requency of patients at higher risk of morbidity (P 
0001) and mortality (P  .001) compared with unit B.
Observed morbidity and mortality rates were 23% (120
atients) and 4.8% (25 patients) in unit A and 17% (39
atients) and 4.4% (10 patients) in unit B, respectively.
The comparison of predicted and observed outcomes is
hown in Table 4. Despite a higher observed morbidity rate c
2 The Journal of Thoracic and Cardiovascular Surgery ● Januan unit A (P  .07), no differences were noted between
bserved and predicted outcomes rates in each unit.
iscussion
n the era of accountability, a reliable analysis of perfor-
ance of health care providers is essential. Because patients
re not randomized between different hospitals and great
ariations can occur because of referral and geographic
atterns, the comparison of outcomes among different cen-
ers might be challenging.
Two recent, important multi-institutional articles from
he American College of Surgeons Oncology Group and the
merican College of Surgeons Commission on Cancer were
imed at setting modern outcome benchmarks and patterns
f care in our specialty. Yet by reporting very different
Figure 2. A, Distribution of quartiles of
predicted risk of morbidity in the 2
units. B, Distribution of quartiles of
predicted risk of mortality in the 2
units.rude outcome figures after major pulmonary resections,
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G
TSikely reflecting different eligibility criteria, they emphasize
he need for risk adjustment.12,13
The quality end points must be necessarily risk adjusted
o account for differences in patients’ baseline and operative
haracteristics. In fact, crude outcome rates might lead to
nappropriate clinical and administrative decisions and
ause unethical risk-averse behaviors.
As a consequence, risk modeling should become an integral
art of any quality-monitoring and quality-improvement pro-
ram. In our specialty risk stratification for audit purposes is
till in its embryonic phase, and only few experiences have
een published on this issue.3-5 In particular, examples of
isk-adjusted multicentric comparative analysis of performance
re lacking.
Recently, the European Association for Cardiothoracic
urgery/European Society of Thoracic Surgeons European
horacic Database project produced a model of in-hospital
ortality from a dataset of more than 3400 lung resections
ollected voluntarily from 27 units in 14 countries over a
eriod of 3 years.7 This work represented the first multi-
nstitutional multinational effort to develop an objective
nstrument to analyze the performance of different units
cross Europe. Future developments of the project are ex-
ected to refine the preliminary model and set performance
enchmarks in Europe.
The present study must be interpreted as an example of
ethods and application of risk models for provider-initiated
ulticentric comparative audit purposes. In fact, it was con-
eived to develop risk-adjusted morbidity and mortality mod-
ls to compare the performance of two different thoracic sur-
ery units. Because no model is better than the one derived
rom the data at hand and because it has been shown that
eady-made models applied to external populations perform
ess well than internally derived models,2,14-16 we elected not
o use existing external models. Furthermore, it is known that
egression models perform better when applied retrospectively
o evaluate the past performance.17 Under a total quality-
anagement perspective, they are not meant to foretell the
uture but to analyze past data to avoid repeating problems
ncountered in the past.17 In this regard the retrospective
pplication of a model as a diagnostic quality instrument to the
ata from which it was developed seems justified, provided a
ross-sample validation (bootstrap) had been performed to
ABLE 4. Comparison of predicted and observed morbidity
Morbidity
nit Observed Predicted P
nit A 23% 22.7% (22%-23.5%)
nit B 17%* 18.2% (17%-19%)
xpected outcomes are presented with 95% confidence limits. *P  .07,easure its reliability.6,10,11 t
The Journal of ThoracIn surgical practice morbidity and mortality are the most
ommonly used clinical indicators of quality. When used as
n outcome variable, however, complications have inherent
roblems: their definition might be complex and subjective,
nd their recording might vary among different institutions
nd even within the same unit during successive periods of
ime. In this work complications were prospectively and
ndependently recorded at two different centers after strict
riteria were preliminarily defined. It was our priority to
ssess the consistency of these definitions between the two
enters, and only those complications that were judged to be
eliably consistent in definition and recording were used for
he analysis (see Appendix 1 for definition of variables).
urthermore, the two main investigators (AB and GR) are
ember of the European Thoracic Database Committee7
nd share the same methods and purposes in variable defi-
ition and database quality control. They were designated as
he clinical audit leads responsible for periodically verifying
he quality of the databases.
The same issue applied for the selection of the variables
ested for a possible association with outcomes. Only those
igh-quality variables that were at least 95% complete in
ach database and were deemed to be consistent between
he two units were selected and used for the analysis.
ariables that were more than 5% incomplete, such as
rgometric parameters (VO2max), blood gas analysis mea-
ures, and albumin concentration, were not included in the
nalysis. We are aware that our models might be imperfect
nd subject to improvements in terms of individual discrim-
nation by the addition of other important factors associated
ith postoperative outcome (ie, ergometric parameters), but
hey are presumably the most reliable ones that we could
erive in the context of this analysis. They showed a good
ace value and content validity and had a good predictive
alidity, as assessed by using the bootstrap bagging simu-
ation. Our models are parsimonious enough to obviate
verfitting problems when applied to medium-sized popu-
ations (particularly when the events are rare, such as mor-
ality). It has recently been shown that increasing the num-
er of predictors does not necessarily improve the
iscrimination of the models.18 Conversely, keeping the
odels as parsimonious as possible might be attractive
ecause it can prevent many problems: cost of data collec-
mortality rates within each unit
Mortality
Observed Predicted P value
4.8% 4.9% (4.5%-5.3%) .9
4.4%† 4.2% (3.6%-4.9%) .9
versus unit B. †P  .8, unit A versus unit B.and
value
.9
.7ion, errors and imprecision in data recording, missing val-
ic and Cardiovascular Surgery ● Volume 133, Number 1 93
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G
TSes, and instability of the model. The ideal model should be
ased on clinical, high-quality, prospectively compiled, pe-
iodically audited, specialty-specific, and procedure-specific
lung resection) databases. We think our models met these
riteria.
Bootstrapping was used to validate the models once they
ere developed from the entire cohort of patients. We and
thers have shown that this method is superior to the tradi-
ional training and test splitting of the dataset, inasmuch as
ore reliable and reproducible predictive equations are gen-
rated.6,10 Each model was tested on 1000 bootstrap sam-
les of the same number of patients as the original dataset,
nd only reliable predictors were selected and factored into
he final regression equations.
As ever, caution is required in interpreting the prediction
f a risk model in an individual patient. The individual
iscrimination of the models (c statistics) was moderate but
n line with the ones reported in other studies.5,8 This
ommon finding in surgical models might be partly due to
et unknown predictors, to the difficulty to represent com-
lex clinical conditions or pathways of care with one or
ore variables, and to catastrophic random events that are
are in the population but important for the single patients.19
owever, the models could be reliably applied to the whole
opulation of lung resection candidates as audit
nstruments.
Another important issue central to every audit analysis is
he definition of quality of care, which most likely is the
eflection of the entire process of care rather than of a single
utcome end point. However, in the absence of more precise
nstruments to evaluate the quality of care in its wholeness,
ultiple end points should be analyzed as a surrogate20
ecause each end point might be associated with a different
spect of the quality of care. In this regard our selected
ndicators (morbidity and mortality) are only a few of the
ultiple end points that could be risk adjusted and used for
udit purposes (eg, postoperative stay, intensive care unit
dmission, technical complications, readmission rate, long-
erm survival, quality of life, and residual functional state).
After development and validation, our models were ap-
lied for predicting the outcomes in the two units, and they
ere able to prevent misleading information derived from
he unadjusted analysis of the performance. In fact, despite
nit A having a higher observed morbidity rate compared
ith that of unit B, the observed outcome rates were in line
ith the predicted ones in each unit. The increased observed
orbidity in unit A could be explained by a worse physio-
ogic state of the patients at the time of operation rather than
y a poorer performance, as shown also by the higher
requency of patients with higher predicted morbidity and
ortality risks in unit A compared with those in unit B.
ithout the use of risk adjustment, unit A would have beenrroneously regarded as underperforming unit B.
4 The Journal of Thoracic and Cardiovascular Surgery ● JanuaIt must be noted that our models were designed for audit
urposes only and were not meant to be used for patient
election, a process that should be based more on individual
linical evaluation rather than on a population-based risk
odel.21
This work confirmed that risk modeling is essential for
rovider profiling and can be easily used for a fair comparison
f the performance between different centers, with the ultimate
oal of improving the quality of surgical care. The costs for
mplementing and managing international multicentric data-
ases (eg, the European Thoracic Surgery Database or the
ociety of Thoracic Surgeons thoracic database) seem there-
ore justified by the benefits that could derive from the quality-
mprovement processes that will be based on them. Even
hough start-up costs might be daunting, ultimately, improved
uality will be cost-efficient, and part of any cost savings
ealized by improved quality can be even factored into the total
osts of gathering and maintaining risk-adjusted data. We think
hat important international cooperative processes for monitor-
ng and standardization of the pathways of surgical care and for
he accreditation of structures cannot leave out of consideration
he use of reliable risk-adjustment models. As physicians, we
hould assume complete responsibility in the evaluation of our
erformance. We should not let managers and administrators
udge our practice through imprecise and improper instru-
ents. At a minimum, it would be in our best interest to
rovide them with the right evaluation tools, which must
ecessarily take into account our proficiency in clinical risk
djustment.
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ppendix 1
reoperative and Operative Variables
he following variables were initially screened for a possible
ssociation with postoperative morbidity and mortality: age, sex,
ody mass index (BMI; in kilograms per square meter), FEV1,
LCO, ppoFEV1, ppoDLCO, cardiac comorbidity, type of disease
benign vs malignant), type of operation (lobectomy vs pneumo-
ectomy), and neodjuvant chemotherapy.
Pulmonary function tests were performed according to the
merican Thoracic Society criteria. Results of spirometry were
ollected after bronchodilator administration. DLCO measurement
as performed by using the single-breath method.
FEV1, ppoFEV1, DLCO, and ppoDLCO values were expressed as
ercentages of predicted value for age, sex, and height. ppoFEV1
nd ppoDLCO values were calculated by estimating the amount of
unctioning parenchyma removed during operation by means of
ronchoscopy, computed tomography, and quantitative lung per-
usion.
For the purpose of the present study and in accordance with
revious investigations,4,5 a concomitant cardiac disease was de-
ned as follows: previous cardiac surgery, previous myocardial
nfarction, history of coronary artery disease, and current treatment
or arrhythmia, cardiac failure, or hypertension. We chose to use t
The Journal of Thorachis definition of cardiac comorbidity for the sake of comparison
ith previous studies and for numeric reasons. In fact, breaking
own the variable in the single cardiac diseases would have
esulted in too many cofactors with limited representation. Al-
hough not weighed, all cardiac conditions included in the variable
re widely recognized cardiac risk factors for noncardiac surgery.
utcome Variables
For the purpose of this study, according to previous studies5,8,9
nd to the European Association for Cardiothoracic Surgery/
uropean Society of Thoracic Surgeons thoracic surgery data-
ase,7 the following complications were included: respiratory fail-
re requiring mechanical ventilation for more than 48 hours,
neumonia (chest radiographic infiltrates, increased white blood
ell count, and fever), atelectasis requiring bronchoscopy, adult
espiratory distress syndrome, pulmonary edema, pulmonary em-
olism, myocardial infarction (suggestive electrocardiographic
ndings and increased myocardial enzymes), hemodynamically
nstable arrhythmia requiring medical treatment, cardiac failure
suggestive chest radiographs, physical examination, and symp-
oms), acute renal failure (change in serum creatinine level 2
g/dL compared with preoperative values), and stroke. For nu-
eric reason, we did not separate cardiac and pulmonary compli-
ations. We also did not weigh complications in keeping with most
f the work done on morbidity; however, we included only those
omplications that increased the complexity of postoperative man-
gement, requiring new treatments or a change of treatment, there-
ore adding up to hospital costs and stay.
iscussion
r Mark S. Allen (Rochester, Minn). Dr Yang, Dr Sonett, mem-
ers, and guests. I have no conflicts to disclose other than that I am
member of the Society of Thoracic Surgeons Database Commit-
ee, and therefore my encouragement to get you to join is hereby
oted.
The authors are to be congratulated on an excellent presentation
n a topic that is becoming increasingly important in the field of
ealth care, and especially surgery. The push for quality improve-
ent and the means to measure what good quality is has already
ecome an important part of our daily practice and can only be
xpected to increase in importance in the future. Analyses such as
hese using data with risk adjustment are very important so that we
an accurately assess the progress we are making in improving the
uality of care we deliver to our patients. This analysis of more
han 700 patients who underwent operations in two separate Eu-
opean hospitals is a good example of how we, the surgeons,
hould lead the effort so that it can be done in a scientific manner
hat is valid and meaningful.
I have several questions for the author. In your report you used
model to predict the number of complications. Because there is
bviously a difference between someone with symptomatic post-
perative atrial fibrillation that is easily controlled with medication
ersus someone with adult respiratory distress syndrome that re-
uires prolonged ventilatory support and intensive care unit care,
ere you able to dissect out from your data the risk factors for
pecific complications, or was there insignificant statistical power
o provide for these types of specific predictions?
ic and Cardiovascular Surgery ● Volume 133, Number 1 95
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G
TSSecond, the question that always arises in the United States is
hether a board-certified thoracic surgeon has a better outcome
han a nonthoracic board-certified surgeon when performing a
ulmonary resection. Do you have the ability in your dataset to
nswer this question using these European data? Were all of these
rocedures performed by certified thoracic surgeons?
Finally, your statistical analysis is quite complicated, and I am
ertainly not a statistical expert; however, I am concerned about
he relatively small sample size you have. With only 743 patients
nd 35 deaths in your analysis, that leaves the standard error for
ge at plus or minus about 30% of the risk coefficient for age and
lus or minus 25% of the coefficient for the percent predicted
ostoperative FEV1. Did your statistician give you an estimate of
ow many additional patients you would need to obtain a lower
tandard of error, say, a plus or minus 5%. In other words, how
arge of a database do we need to accumulate to get a more specific
redictive number?
Again, I appreciate your efforts to provide us with stratification
n the field of pulmonary surgery and appreciate the opportunity to
iscuss this article. Thank you.
Dr Brunelli. Thank you, Dr Allen, for your kind comments and
our questions.
As to the first question, the complications, we did not weight
he complications, and therefore each complication was accounted
or similarly, and I think we did not have the numbers to individ-
ally dissect the complications, for example, to make separate
odels for pulmonary and cardiac complications. Therefore, the
umbers and the statistical power precluded us from making this
ubgroup analysis.
You asked about the qualifications of the surgeons. These two
enters were dedicated thoracic surgery units, and all of the sur-
eons were qualified, certified thoracic surgeons. Therefore we
ould not assess the differences between credentials of surgeons in
elation to outcome.
Finally, sample size is a major concern in our specialty when
ealing with audit analysis. These are the numbers. Of course, 35
eaths seems to be a low number, but we are confident that the
esults are reliable. We used bootstrap analysis to validate the
odel. The mortality model had two predictors, and therefore it is
ot overfitted, and the predictors had high stability with bootstrap
nalysis, which means that we repeated the regression analysis in
000 new simulated samples drawn with replacement from the
riginal dataset, and these variables turned out to be significant in
ore than 85% or 90% of cases. It took us 5 years to aggregate
hese data, and these two units have the average volume load in
urope, and this is a major concern. Even if you aggregate mul-iple units, let us say 10, 20, or 100 units, when dealing with audit t
6 The Journal of Thoracic and Cardiovascular Surgery ● Januand comparison between the units, we have to then apply the
odels to the single units or to the single surgeon and then you can
ave problems. Perhaps we have to shift from outcome measures
o other measures of quality of care, perhaps process measures,
hich are less affected by random noise and numbers and perhaps
ore linked to the quality. Therefore, the main purpose of this
tudy was to provide an example or method, and of course there
re limitations, but I think the limitations are inherent to the
utcome measures selected. For this first audit, we wanted to do a
omparative audit between two thoracic surgery units using the
wo most commonly used outcome measures, which are morbidity
nd mortality. But of course sample size is very important, and
erhaps we can change our mentality and shift from outcome
easures to process measures.
Dr Stephen C. Yang (Baltimore, Md). I am less of a statisti-
ian than Dr Allen, but how would you see the results to be
ifferent if there was a significant difference in mortality rates or
omplications between the two institutions? Would this model still
old?
Dr Brunelli. There was no significant difference—
Dr Yang. I know, but what if?
Dr Brunelli. Oh, what if? You have to assess whether there is
difference in the predicted and observed mortality within the
nits. Therefore let us say we have a big difference in mortality
ate, observed mortality rate between the two units. If the units
ere not in line with the predicted values, you can be confident
hat the difference is not due to poor performance but perhaps a
ifferent case mix.
Dr Joshua R. Sonett (New York, NY). But dead is dead in the
nd, and it does not matter what your risk model is if you have very
ad outcomes. If it is much higher, then maybe that is a reflection
f patient selection, which must be considered when evaluating
rograms and surgeons.
Dr Brunelli. Yes, but we are dealing with audit analysis and
erformance evaluation. Therefore it is unfair to judge a unit on
rude mortality rate without taking into account the case mix and
he prevalence of risk factors.
Dr Yang. Well, even if the case mixes are different, what about
he experience of the surgeons? Are they fairly well balanced
etween the 2 units?
Dr Brunelli. Yes. We explored this, and the structural and
rganizational characteristics of the two units were remarkably
imilar in credentials, experience of the surgeons, nurse-to-patient
atio, intensive care unit policy, and management. They both were
edicated thoracic surgery wards. We were confident that the
ualifications and experience of the surgeons and the structure of
he units were similar.
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